%PDF-1.4
%
35 0 obj
<>
endobj
32 0 obj
<>
endobj
106 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-12-14T17:50:45Z
2024-03-29T00:17:36-07:00
QuarkXPressª: AdobePS 8.6 (219)
2024-03-29T00:17:36-07:00
application/pdf
Heather
2002-22.nov02
uuid:9e9ea80e-1dd1-11b2-0a00-7109276d7200
uuid:9e9ea812-1dd1-11b2-0a00-b80000000000
endstream
endobj
21 0 obj
<>
endobj
22 0 obj
<>
endobj
36 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
4 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
7 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
121 0 obj
[125 0 R]
endobj
122 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
BT
/CS0 cs 0 0 0 1 scn
/GS1 gs
/TT0 1 Tf
0.0593 Tw 10 0 0 10 54 713.1616 Tm
(enzymes due to the ingestion of immune complexes by the)Tj
0.22549 Tw 0 -1.2 TD
(polymorphonuclear leukocytes results in vessel damage)Tj
0 Tw 6.5 0 0 6.5 288.2501 704.4615 Tm
(2)Tj
10 0 0 10 291.5001 701.1616 Tm
(.)Tj
-0.0248 Tw -23.75 -1.2 Td
[(However)39.8 (, the possible influence of IL-8 gene polymorphism)]TJ
0.1154 Tw T*
[(in the development of nephritis in HSP)-328.6 (needs to be eluci-)]TJ
0 Tw T*
(dated. )Tj
0.24001 Tw 1.2 -1.2 Td
(IL-8 induces a rapid and active change in neutrophil)Tj
-0.0076 Tw -1.2 -1.2 Td
(shape resulting from the polymerization and de-polymeriza-)Tj
0.0018 Tw T*
(tion of actin)Tj
0 Tw 6.5 0 0 6.5 102.3541 632.4615 Tm
(5)Tj
0.0018 Tw 10 0 0 10 105.6041 629.1616 Tm
(. IL-8 would be implicated in the up-regulation)Tj
0.26691 Tw -5.1604 -1.2 Td
(and activation of integrins through which the leukocyte)Tj
0.0519 Tw T*
(adhere to endothelial cell before emigration)Tj
0 Tw 6.5 0 0 6.5 231.2314 608.4615 Tm
(13)Tj
0.0341 Tw 10 0 0 10 237.7314 605.1616 Tm
[(. W)39.8 (ith )-17.8 (respect)]TJ
0.1431 Tw -18.3731 -1.2 Td
(to this, the chemokine receptors CXCR1 and CXCR2 are)Tj
-0.01199 Tw T*
[(almost exclusively found in neutrophils. )17.8 (These receptors are)]TJ
0.2623 Tw T*
(principally implicated in antibacterial defense)Tj
0 Tw 6.5 0 0 6.5 247.7399 572.4615 Tm
(5)Tj
-0.00011 Tc 0.26241 Tw 10 0 0 10 250.9899 569.1616 Tm
(. Of note,)Tj
0 Tc 0.3692 Tw -19.699 -1.2 Td
[(infectious agents, in particular)39.8 (, beta hemolytic strepto-)]TJ
0.00571 Tw T*
(coccus, seem to be implicated in the development of HSP)Tj
0 Tw 6.5 0 0 6.5 285.0002 548.4615 Tm
(14)Tj
10 0 0 10 291.5001 545.1616 Tm
(.)Tj
0.21651 Tw -23.75 -1.2 Td
(The implication of these receptors in the acute response)Tj
0.02859 Tw T*
(might explain why IL-8 polymorphism was associated with)Tj
0.0218 Tw T*
(disease susceptibility to renal and possibly to GI manifesta-)Tj
-0.00011 Tc 0.1472 Tw T*
(tions as a trigger factor of inflammatory response against)Tj
0 Tc 0.0842 Tw T*
(infectious agents but not linked to development of chronic)Tj
0.0209 Tw T*
(disease. Based on that, investigations of chemokine antago-)Tj
-0.00011 Tc 0.1895 Tw T*
(nists of IL-8 or specifically their receptors might have a)Tj
0 Tc 0.1339 Tw T*
[(clinical implication. Other genes, however)39.8 (, may be impli-)]TJ
0.20261 Tw T*
(cated in the development of persistent and chronic renal)Tj
0.2018 Tw T*
(damage. In this regard, in our patients the IL-1 receptor)Tj
-0.00011 Tc 0.0016 Tw T*
(antagonist \(IL-1ra\) gene polymorphism was associated with)Tj
0 Tc 0.09711 Tw T*
(severe renal involvement and renal sequelae in HSP)Tj
0 Tw 6.5 0 0 6.5 268.7649 404.4616 Tm
(15)Tj
-0.00011 Tc 0.09711 Tw 10 0 0 10 275.2648 401.1616 Tm
(. IL-)Tj
0 Tc 0.0686 Tw -22.1265 -1.2 Td
(1ra gene polymorphism was directly implicated in severity)Tj
-0.01891 Tw T*
[(and outcome, but not in susceptibility)64.9 (, of unselected patients)]TJ
0.11189 Tw T*
(with cutaneous vasculitis. No association of this polymor-)Tj
0.16721 Tw T*
(phism was observed in patients with vasculitis limited to)Tj
0.0428 Tw T*
(skin, but the carriage of IL-1 receptor antagonist allele 2 in)Tj
-0.00011 Tc 0.1687 Tw T*
[(HSP)-381.9 (patients was associated with a higher risk of severe)]TJ
0 Tc 0.02499 Tw T*
(renal manifestations and renal sequelae)Tj
0 Tw 6.5 0 0 6.5 212.1387 320.4616 Tm
(15)Tj
10 0 0 10 218.6387 317.1616 Tm
(.)Tj
0.16679 Tw -15.2639 -1.2 Td
(Additional studies in other populations are required to)Tj
0.0345 Tw -1.2 -1.2 Td
(further delineate the role of IL-8 in the clinical spectrum of)Tj
-0.0004 Tc 0 Tw T*
[(HSP)110.4 (.)]TJ
/TT1 1 Tf
-0.00011 Tc 26.4 43.2 Td
(REFERENCES)Tj
/TT0 1 Tf
0.02499 Tw 8 0 0 8 325 703.1616 Tm
[(1.)-875.1 (Jennette JC, Falk RJ, )54.8 (Andrassy K, et al. Nomenclature of systemic)]TJ
0 Tc 1.675 -1.25 Td
(vasculitides: proposal of an international consensus conference.)Tj
0 -1.25 TD
(Arthritis Rheum 1994;37:187-92.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(2.)-875.1 (Gonzalez-Gay MA, Garcia-Porrua C. Henoch-Sch\366nlein purpura.)]TJ
1.675 -1.25 Td
[(In: Ball GV)128.8 (, Bridges SL, editors. )17.7 (V)111 (asculitis )17.7 (T)69.7 (extbook. New )36.8 (Y)100 (ork:)]TJ
T*
(Oxford University Press 2002;476-94.)Tj
0 Tc -1.675 -1.25 Td
[(3.)-875 (Rossi D, Zlotnik )54.9 (A. )17.8 (The biology of chemokines and their receptors.)]TJ
1.675 -1.25 Td
(Ann Rev Immunol 2000;18:217-42.)Tj
-1.675 -1.25 Td
[(4.)-875 (Bleul CC, Farzan M, Choe H, et al. )17.8 (The lymphocyte)]TJ
1.675 -1.25 Td
(chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks)Tj
-0.00011 Tc T*
[(HIV)91.7 (-1 entry)64.9 (. Nature 1996;382:829-33.)]TJ
0 Tc -1.675 -1.25 Td
[(5.)-875 (Bagglioni M. Chemokines in pathology and medicine. J Intern Med)]TJ
0 Tw 1.675 -1.25 Td
(2001;250:91-104.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(6.)-875.1 (Amoli MM, )17.7 (Thomson )17.7 (W)91.7 (, Hajeer )54.8 (AH, et al. HLA-DRB1*01 )]TJ
0 Tc 1.675 -1.25 Td
(association with Henoch-Sch\366nlein purpura in patients from)Tj
T*
(Northwest Spain. J Rheumatol 2001;28:1266-70.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(7.)-875.1 (Michel BA, Hunder GG, Bloch DA, Calabrese LH.)]TJ
0 Tc 1.675 -1.25 Td
[(Hypersensitivity vasculitis and Henoch-Sch\366nlein purpura: )54.8 (A)]TJ
T*
(comparison between the 2 disorders. J Rheumatol 1992;19:721-8.)Tj
-1.675 -1.25 Td
[(8.)-875 (Y)111.1 (u )36.9 (Y)129.2 (, Chadee K. )17.8 (The 3\222-untranslated region of human interleukin-8)]TJ
-0.00011 Tc 1.675 -1.25 Td
[(mRNA)-220.2 (suppresses IL-8 gene expression. Immunology)]TJ
0 Tc 0 Tw T*
(2001;102:498-505.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(9.)-875.1 (Amoli MM, )17.7 (Thomson )17.7 (W)91.7 (, Gonzalez-Gay MA, Ollier )17.7 (WER. )17.7 (T)69.7 (w)0.1 (o)]TJ
0 Tc 1.675 -1.25 Td
(polymorphisms in the epithelial cell-derived neutrophil-activating)Tj
-0.00011 Tc T*
(peptide \(ENA-78\) gene. Genes Immun \(in press\).)Tj
-2.175 -1.25 Td
[(10.)-875.1 (Makki RF)79.7 (, al Sharif F)79.7 (, Gonzalez-Gay MA, Garcia-Porrua C, Ollier)]TJ
0 Tc 2.175 -1.25 Td
[(WE, Hajeer )54.9 (AH. RANTES gene polymorphism in polymyalgia)]TJ
T*
(rheumatica, giant cell arteritis and rheumatoid arthritis. Clin Exp)Tj
T*
(Rheumatol 2000;18:391-3.)Tj
-2.1381 -1.25 Td
[(1)36.9 (1.)-875 (Amoroso )54.9 (A, Berrino M, Canale L, et al. Immunogenetics of)]TJ
2.1381 -1.25 Td
(Henoch-Schoenlein disease. Eur J Immunogenet 1997;24:323-33.)Tj
-2.175 -1.25 Td
[(12.)-875 (Amoli MM, Mattey DL, Calvi\361o MC, et al. Polymorphism at codon)]TJ
-0.00011 Tc 2.175 -1.25 Td
(469 of the intercellular adhesion molecule-1 \(ICAM-1\) locus is)Tj
0 Tc T*
(associated with protection against severe gastrointestinal )Tj
T*
(complications in Henoch-Sch\366nlein purpura. J Rheumatol)Tj
0 Tw T*
(2001;28:1014-8.)Tj
0.02499 Tw -2.175 -1.25 Td
[(13.)-875 (Springer )17.8 (T)79.8 (A. )17.8 (T)34.9 (raf)17.8 (fic signals for lymphocyte recirculation and)]TJ
2.175 -1.25 Td
(leukocyte emigration: the multistep paradigm. Cell 1994;76:301-14.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(14.)-875.1 (Calvi\361o MC, Llorca J, Garcia-Porrua C, Fernandez-Iglesias JL,)]TJ
2.175 -1.25 Td
[(Rodriguez-Ledo P)110.7 (, Gonzalez-Gay MA. Henoch-Sch\366nlein purpura)]TJ
T*
[(in children from Northwestern Spain: )54.8 (A)-219.9 (20-year epidemiologic and)]TJ
0 Tc T*
[(clinical study)64.9 (. Medicine Baltimore 2001;80:279-90.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(15.)-875.1 (Amoli MM, )17.7 (Thomson )17.7 (W)91.7 (, Hajeer )54.8 (AH, et al. Interleukin-1 receptor)]TJ
0 Tc 2.175 -1.25 Td
(antagonist gene polymorphism is associated with severe renal)Tj
T*
(involvement and renal sequelae in Henoch-Sch\366nlein purpura. )Tj
T*
(J Rheumatol 2002;29:1404-7.)Tj
ET
/CS0 CS 0 0 0 1 SCN
54 54 m
558 54 l
S
BT
/TT2 1 Tf
8 0 0 8 420.9531 35.9844 Tm
[(The Journal of Rheumatology 2002; 29:1)74 (1)]TJ
0 Tw -45.8691 -0.0313 Td
(2370)Tj
ET
0 0 0 0 scn
/GS0 gs
104.25 59.75 407.5 -10.83 re
f*
0.5 w
104.25 59.75 407.5 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_0 8 Tf
120.092 51 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2002. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_1 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
77 0 obj
<>
endobj
112 0 obj
<>
endobj
44 0 obj
<>
endobj
50 0 obj
<>
endobj
38 0 obj
<>
endobj
40 0 obj
<>
endobj
72 0 obj
<>stream
HV pUBBr@6d
dpDrH8*)B
BeX
Dդ-
E@C)cd) *",0_O¥U[oy?7 o9cS:*HB+;\kKI{Pu؏XGgdbF ]! iwIY"؎2]:|ʋQI\8|u)t8!>Qk
#uAoc)jpc#UFL('7|eb^N`HqiG,#NGD\zEOx0#'*F";bY^k+gE?c1|eb5Xh+!
3#w2q78qWD @ܓ0AHDO[d|NAUԕeZd'd/"Qk[Od`3Ј/4Qaq^iȡVf'˚/\[Sf{ٙuzSWۋ;{,Xw
?8NЈ[x@1"#^r76]DX,T8J~9Y.+g<-W
).:\-TwhTJv:z?~)<%\>f9X+ӪYzvH%0ؑ,vupM4؛s3;اOx09\af , Tֹ=sΌ3 "_$1ELL*渒F,b8 [6۫F2.9<J.k[r|Wn#˰RUҕ>>e2F *seMٮ|PSUu~,ǏZ-Gk,U-is=Go4o8W878ğ=EǤqX"&>BZ}Rzq'k$N$H
|a]".:t`=o1\US<ŀ{9]Yu~6#;ޱCZjJrĄvmi:ULQN*R gfFT3#6o)>!:EÞ1@LC_Yz,=,E>ٺc^C\YՌӊEݗTM}ʲ/eAu_oFCAu-&rʒ8>37S}b3oMq
٦-20#Mgeh} V껲VaZ +(NJޢMhx/'=f|Qia0f&6`sUF3\V72m6$J- hcQ`͓C&/tNN4XQ ~e>b!4~{Ok
IX{JZ4{IԾ9jb,LH' T_%}*K3>EaFBqjqlxiIYHnCõeffO Dh#^J3Ũ
ycr-[Y42f8cZnxr
L5jmMC#Ӹ_x3*ѧu\B[_YS$uIDok$
Q%V?RT/}7S-I5VG?lA]>EyV] _ygݴIEDR$6'ЧTyvgpN%9lc&L;d5r}O孥jeըnR_ֶَuuf?N;c
)LJ2s@ڔ]I`#:.!HDSg|;Wۿ
͘=I.Gϧm&騒fQzXe:ys~Sߐ$5P=?UzXΛHH98aY&+I֗%adcK?AYFdƐ$çC!1q삕0W'13h
5e!@BJM(餁S3aI0L*oWЙ4vݷ=&gFN`6ǥ[<"P/1AAa81vL?v 'jRCG[X,w+J rk#6cا]x5bl)`1Aug{OS0ϓJ0o#xߣڣ.}z~=p
rb:s' xA.C^-˝dzAs y3;
3E6 =ȏ@a3Xf9rPhx1J1W%2btΑ>2BG|d5шzWI56RF 9`! F~`H?@F 25r@+ y ]#/i9 id?^#= F kd7 H1FF.Fjh'V*m\w[HWU쐿鐧;+Ap-*fyYkfyA\\
>d<͵\߇OChH+CrAHgO'O.>h=u&) |
ϧfIQ9Z?|_H8E
$XphZ:hx=
.Q47.H
ь"Jˣt^mXO델5pZp.^)7T .tƧ5QzDVMQG#'tz3M_WK=,=EFcd$Ivi$M/wWoIz
I|{{x7X7{zmOue+{o6ze>KI
d:vaVAo,MqV{1YdyH9
|jXR.KR([%u.EZ"y+ɐi0A086-Rdӛ^6
; 2C A^9 d i{3dM5%R?NI/!>po6?W1|d\쎴9.o3/^gS}pSxEHӯa)YNIg4 *'NIjjZ؉ik+aw 'A&[X;
hk9
~!2s6$i.Rha@#\d7M3x/t{ R\ʪO:4f|+)ds߀ 1*Vd
%bTfcqy-{x1^_$WQ:5D-mQ"g?V^&VU.LƖs
2'@ Eb ƮT2H<mBGkxPH:ҡ!Y<{is]W||ocF10f]?ĭ(6%B8hXflہ7~Qѹms>]{+ۤ709
mCv4+f
:d]Օ9EKݜ1]ALyjs0?OGm{rسM:WXeZ*H˫{GًvWWp/}=8/3Jx|0~;יOa>EBFа'8|pY?.pQg
+E
?7|!
u8 VE3W4e Ba6-ܥv 7qvZZZYJlKd[d /m0 `an0RDRji.M@@ LP#Sj:tC@B